Operating Margin of Serina Therapeutics, Inc. from 31 Dec 2017 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
The operating margin measures the profit a company makes on a dollar of sales after accounting for the direct costs involved in earning those revenues.
Summary
Serina Therapeutics, Inc. quarterly and annual Operating Margin in % history and change rate from 31 Dec 2017 to 30 Sep 2025.
  • Serina Therapeutics, Inc. Operating Margin for the quarter ending 30 Sep 2025 was -20141%, a 5548% decline year-over-year.
  • Serina Therapeutics, Inc. annual Operating Margin for 2024 was -30443%, a 30576% decline from 2023.
  • Serina Therapeutics, Inc. annual Operating Margin for 2023 was -99%, a 100% increase from 2022.
  • Serina Therapeutics, Inc. annual Operating Margin for 2022 was -20515%, a 272% decline from 2021.
Operating Margin, Quarterly (%)
Operating Margin, YoY Quarterly Change (%)
Operating Margin, Annual (%)
Operating Margin, YoY Annual Change (%)

Serina Therapeutics, Inc. Quarterly Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -20141% -19785% -5548% 01 Jul 2025 30 Sep 2025
Q2 2025 -17142% -16908% -7239% 01 Apr 2025 30 Jun 2025
Q1 2025 -40363% -40219% -28032% 01 Jan 2025 31 Mar 2025
Q4 2024 -30443% -30344% -30576% 01 Oct 2024 31 Dec 2024
Q3 2024 -357% +6606% +95% 01 Jul 2024 30 Sep 2024
Q2 2024 -234% +9468% +98% 01 Apr 2024 30 Jun 2024
Q1 2024 -143% +9831% +99% 01 Jan 2024 31 Mar 2024
Q4 2023 -99% +20415% +100% 01 Oct 2023 31 Dec 2023
Q3 2023 -6962% +6359% +48% 01 Jul 2023 30 Sep 2023
Q2 2023 -9702% +863% +8.2% 01 Apr 2023 30 Jun 2023
Q1 2023 -9975% -1590% -19% 01 Jan 2023 31 Mar 2023
Q4 2022 -20515% -15006% -272% 01 Oct 2022 31 Dec 2022
Q3 2022 -13321% -10269% -336% 01 Jul 2022 30 Sep 2022
Q2 2022 -10565% -7716% -271% 01 Apr 2022 30 Jun 2022
Q1 2022 -8385% -5556% -196% 01 Jan 2022 31 Mar 2022
Q4 2021 -5509% -2711% -97% 01 Oct 2021 31 Dec 2021
Q3 2021 -3052% -1657% -119% 01 Jul 2021 30 Sep 2021
Q2 2021 -2849% -1809% -174% 01 Apr 2021 30 Jun 2021
Q1 2021 -2829% -1958% -225% 01 Jan 2021 31 Mar 2021
Q4 2020 -2798% -2071% -285% 01 Oct 2020 31 Dec 2020
Q3 2020 -1395% -510% -58% 01 Jul 2020 30 Sep 2020
Q2 2020 -1039% -210% -25% 01 Apr 2020 30 Jun 2020
Q1 2020 -871% -171% -24% 01 Jan 2020 31 Mar 2020
Q4 2019 -727% +79% +9.8% 01 Oct 2019 31 Dec 2019
Q3 2019 -885% 01 Jul 2019 30 Sep 2019
Q2 2019 -830% 01 Apr 2019 30 Jun 2019
Q1 2019 -700% 01 Jan 2019 31 Mar 2019
Q4 2018 -806% 01 Oct 2018 31 Dec 2018

Serina Therapeutics, Inc. Annual Operating Margin (%)

Period Value YoY Chg Change % Start Date End Date
2024 -30443% -30344% -30576% 01 Jan 2024 31 Dec 2024
2023 -99% +20415% +100% 01 Jan 2023 31 Dec 2023
2022 -20515% -15006% -272% 01 Jan 2022 31 Dec 2022
2021 -5509% -2711% -97% 01 Jan 2021 31 Dec 2021
2020 -2798% -2071% -285% 01 Jan 2020 31 Dec 2020
2019 -727% +79% +9.8% 01 Jan 2019 31 Dec 2019
2018 -806% -331% -70% 01 Jan 2018 31 Dec 2018
2017 -475% 01 Jan 2017 31 Dec 2017
* An asterisk sign (*) next to the value indicates that the value is likely invalid.